Literature DB >> 8256216

Amiodarone-induced thyrotoxicosis: clinical presentation and expanded indications for thyroidectomy.

D C Mulligan1, C R McHenry, W Kinney, C B Esselstyn.   

Abstract

BACKGROUND: Amiodarone-induced thyrotoxicosis (AIT) is a rare disorder that is frequently refractory to conventional pharmacologic therapy.
METHODS: An analysis of seven patients who underwent thyroidectomy for control of AIT between 1987 and 1993 was completed to examine the clinical manifestations and the indications for surgical therapy.
RESULTS: Five men and two women, 53 to 72 years of age, had AIT after 3 to 55 months of amiodarone treatment (mean, 21 months). The primary manifestations of AIT were ventricular tachycardia (five), exacerbation of chronic pulmonary disease (one), and occult hyperthyroidism (one). Medical therapy included propylthiouracil in doses up to 1200 mg/day in five patients, a beta-receptor antagonist in three, and withdrawal of amiodarone in five. Near-total or total thyroidectomy resulted in resolution of thyrotoxicosis in all patients. Morbidity included pneumonia (one) and cardiac dysrhythmias (two). One patient died of ventricular dysrhythmias 4 months after thyroidectomy. The mean thyroid weight was 50 gm (range, 17 to 216 gm). Microscopic examination showed destructive follicular lesions with fibrosis in all patients. Associated thyroid pathologic condition included multinodular goiter in four patients and a follicular adenoma in one.
CONCLUSIONS: AIT may be clinically occult or manifested by unusual symptoms requiring a high index of suspicion for diagnosis. Near-total thyroidectomy is safe and effective in producing rapid resolution of AIT and is indicated for the initial treatment of patients who present with a resurgence of life-threatening cardiac arrhythmias and for all patients with AIT refractory to medical therapy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8256216

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  6 in total

1.  [Thyrotoxic crisis].

Authors:  K Reschke; H Lehnert
Journal:  Internist (Berl)       Date:  2003-10       Impact factor: 0.743

Review 2.  Total thyroidectomy for amiodarone-associated thyrotoxicosis in patients with severe cardiac disease.

Authors:  Jenny Gough; Ian R Gough
Journal:  World J Surg       Date:  2006-11       Impact factor: 3.352

3.  Management of amiodarone-related thyroid problems.

Authors:  Shashithej K Narayana; David R Woods; Christopher J Boos
Journal:  Ther Adv Endocrinol Metab       Date:  2011-06       Impact factor: 3.565

4.  Iopanoic acid rapidly controls type I amiodarone-induced thyrotoxicosis prior to thyroidectomy.

Authors:  F Bogazzi; F Aghini-Lombardi; C Cosci; I Lupi; F Santini; M L Tanda; P Miccoli; F Basolo; A Pinchera; L Bartalena; L E Braverman; E Martino
Journal:  J Endocrinol Invest       Date:  2002-02       Impact factor: 4.256

5.  Surgical management of amiodarone-associated thyrotoxicosis: Mayo Clinic experience.

Authors:  Scott G Houghton; David R Farley; Michael D Brennan; Jon A van Heerden; Geoffrey B Thompson; Clive S Grant
Journal:  World J Surg       Date:  2004-11       Impact factor: 3.352

6.  Early surgery: a favorable prognosticator in amiodarone-induced thyrotoxicosis-a single-center experience with 53 cases.

Authors:  Sohail Bakkar; Piermarco Papini; Daniele Cappellani; Francesco Forfori; Claudio Di Salvo; Sonia Catarsi; Carlo Enrico Ambrosini; Paolo Miccoli; Fausto Bogazzi; Gabriele Materazzi
Journal:  Updates Surg       Date:  2022-05-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.